Salarius Pharmaceuticals, Inc. , a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments.
Salarius Pharmaceuticals stock last closed at $6.68, down 3.57% from the previous day, and has decreased 76.56% in one year. It has underperformed other stocks in the Biotechnology industry by 0.11 percentage points. Salarius Pharmaceuticals stock is currently +7.57% from its 52-week low of $6.21, and -93.81% from its 52-week high of $108.00.
As of Aug 18, 2025, there are 509,706 shares of SLRX outstanding. The market value of SLRX is $3.40M. In the past 24 hours, 155,000 SLRX shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy SLRX stock.
Based on our analysis, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, it's time to fill out some personal information so you are able to invest in SLRX stock today.
Now that you've created your account on our top ranked stock market app, you need to deposit funds:
Check out the walkthrough below for more details transferring funds into your new investment account.
After you have figured out the best place to buy Salarius Pharmaceuticals stock, it's crucial to evaluate their stock prior to buying, so you truly wrap your head around the risk as well as the upside.
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on SLRX's stock page.
You can use many financial metrics, analyses, models, and charts to gauge SLRX's intrinsic value.
You can do more valuation research on SLRX's stock here.
You can dig deeper into what analysts are saying on the Salarius Pharmaceuticals stock forecast page.
Last year, SLRX revenue was $0.00. In the last five year, SLRX's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 64.4%.
Find out more about SLRX's earnings and revenue performance here.
Over the past year, executives and large shareholders at SLRX have not bought or sold any shares.
Research more about who owns SLRX stock here.
No, Salarius Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two primary types of orders:
Click the Open button and eToro will execute your order.
If you require more help investing in stocks on eToro, click the how to video below:
Now that you own some shares in SLRX, you'll want to keep up with your new shares.
Make a watchlist to see the latest developments about your SLRX stock.
To reiterate, here are the 6 steps you need to take to buy Salarius Pharmaceuticals stock right now:
If you need a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to watch your investment in Salarius Pharmaceuticals, create a watchlist on WallStreetZen today.